Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer
Gumersindo Pérez Manga, Parham Khosravi Shahi, Miguel Méndez Ureña, Rosa Quiben Pereira, María Isabel Palomero Plaza, Yann Izarzugaza Peron, Ricardo González Del Val, Joaquín Belón Carrión, EsperanzaVolume:
17
Language:
english
Pages:
7
DOI:
10.1007/s12282-009-0136-6
Date:
July, 2010
File:
PDF, 214 KB
english, 2010